Welcome to LookChem.com Sign In|Join Free

CAS

  • or

119768-48-8

Post Buying Request

119768-48-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

119768-48-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 119768-48-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,7,6 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 119768-48:
(8*1)+(7*1)+(6*9)+(5*7)+(4*6)+(3*8)+(2*4)+(1*8)=168
168 % 10 = 8
So 119768-48-8 is a valid CAS Registry Number.

119768-48-8Relevant articles and documents

o-Boronato- and o-Trifluoroborato - Phosphonium Salts Supported by L-α-Amino Acid Side Chain

Bernard, Julie,Malacea-Kabbara, Raluca,Clemente, Gon?alo S.,Burke, Benjamin P.,Eymin, Marie-Jo?lle,Archibald, Stephen J.,Jugé, Sylvain

, p. 4289 - 4298 (2015)

(Figure Presented) The synthesis of o-boronato- and o-trifluoroborato-phosphonium salts supported by the l-amino acid side chain is described. The synthesis of these new class of amino acid derivatives was achieved by stereoselective quaternization of o-(

VERSATILE AND STEREOSPECIFIC SYNTHESIS OF GAMMA,DELTA -UNSATURATED AMINO ACIDS BY WITTIG REACTION

-

Page/Page column 39; 40, (2013/03/28)

The present invention relates to γ,δ-unsaturated a-amino acids of general formula (I). The present invention also provides a versatile process for the stereospecific synthesis of said compounds of formula (I), involving a Wittig reaction. The present invention also relates to intermediate products of general formulae (II) and (III), as shown below, which are involved in the synthesis of compounds (I).

NOVEL GAMMA-LACTAMS AS BETA-SECRETASE INHIBITORS

-

Page 43; 113, (2008/06/13)

There is provided a series of novel substituted gamma-lactams of Formula (I) wherein R1, R2, R3, R4 and R5 are defined herein, their pharmaceutical compositions and methods of use. These novel compounds inhibit the processing of amyloid precursor protein (APP) by β-secretase and, more specifically, inhibit the production of aβ-peptide. The present invention is directed to compounds useful in the treatment of neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 119768-48-8